(Q56565657)

https://api.crossref.org/works/10.1002%2FEJOC.200600975

Unnatural amino acid mutagenesis: a precise tool for probing protein structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

A field guide to foldamers

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

β-Peptide Foldamers: Robust Helix Formation in a New Family of β-Amino Acid Oligomers

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Foldamers: A Manifesto

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Peptide Folding: When Simulation Meets Experiment

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

C9 helices and ribbons in gamma-peptides: crystal structures of gabapentin oligomers

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

A left-handed 9-helix in gamma-peptides: synthesis and conformational studies of oligomers with dipeptide repeats of C-linked carbo-gamma4-amino acids and gamma-aminobutyric acid

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Helices and other secondary structures of beta- and gamma-peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Antiviral agents. 2. Structure-activity relations of compounds related to 1-adamantanamine

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Adamantanealkanamines as potential antidepressant and anti-Parkinson agents

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Biologically active polycycloalkanes. 1. Antiviral adamantane derivatives

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

How to overcome resistance of influenza A viruses against adamantane derivatives

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

A new reaction of nitriles; amides from alkenes and mononitriles

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

H-coupled electron transfer in alkane C-h activations with halogen electrophiles

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Selective Alkane Transformations via Radicals and Radical Cations: Insights into the Activation Step from Experiment and Theory

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Glutamatergic drugs in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Selective radical reactions in multiphase systems: phase-transfer halogenations of alkanes

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Ultrasonic acceleration of iodination of unactivated aliphatic hydrocarbons

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Theoretical and experimental studies of optically active bridgehead-substituted adamantanes and related compounds

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

In Search of Peptide-Based Catalysts for Asymmetric Organic Synthesis

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Role of secondary structure in the asymmetric acylation reaction catalyzed by peptides based on chiral C alpha-tetrasubstituted alpha-amino acids

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Metal-free organocatalysis through explicit hydrogen bonding interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Method for Determination of the Amino Acid Sequence in Peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

36 Automated edman degradation: The protein sequenator

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021

Alkenylthioimidoyl radicals: competition between beta-scission and cyclization to dihydrothiophen-2-ylidene-amines.

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200600975

7 January 2021